{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System Trimethoprim-sulfamethoxazole 0.0625/1.2-16/304 \u03bcg/mL",
        "BD PhoenixM Automated Microbiology System Streptococcus ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K050865",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 20, 2005",
    "Summary Letter Received Date": "April 6, 2005",
    "Submission Date": "April 1, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trimethoprim-sulfamethoxazole"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth-based microdilution",
        "Automated identification and susceptibility testing",
        "Redox indicator-based growth determination"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System for Streptococcus susceptibility testing using trimethoprim-sulfamethoxazole panels",
    "Indications for Use Summary": "Intended for rapid identification and in vitro quantitative determination of antimicrobial susceptibility by MIC of isolates from pure cultures of most Gram-negative and Gram-positive bacteria, with Streptococcus ID/AST or AST only panels containing trimethoprim-sulfamethoxazole.",
    "fda_folder": "Microbiology"
}